ATYR

aTyr Pharma
ATYR

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $6.5M invested in aTyr Pharma in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

26% less capital invested

Capital invested by funds: $8.73M → $6.5M (-$2.23M)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$424K
2
+$216K
3
+$138K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$107K
5
Federated Hermes
Federated Hermes
Pennsylvania
+$76.6K

Top Sellers

1
-$25K
2
-$14K
3
-$10K
4
Northern Trust
Northern Trust
Illinois
-$10K
5
TSS
Two Sigma Securities
New York
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.93M
2
$1.72M
3
$802K
4
$678K
5
$583K
6
$457K
7
$107K
8
$45K
9
$38K
10
$32K
11
$30K
12
$25K
13
$21K
14
$20K
15
$18K
16
$2K
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–